The role of NRF2 in reflux-induced esophageal adenocarcinomas
NRF2在反流诱发的食管腺癌中的作用
基本信息
- 批准号:10331804
- 负责人:
- 金额:$ 34.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdenocarcinoma CellAdultAffectAntineoplastic AgentsAntioxidantsBarrett EsophagusBenignBile RefluxBiologicalCell SurvivalCell modelCellsChronicClinicalDNA DamageDataDevelopmentDiagnosticDiseaseEpithelialErythroid CellsEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaEsophagusEtiologyExposure toFailureFamilyFamily memberGPX3 geneGastroesophageal reflux diseaseGene ExpressionGenesGenetic TranscriptionGlandular MetaplasiaGlutathioneGlutathione S-TransferaseGoalsHigh grade dysplasiaIn VitroIncidenceIntestinesKnowledgeLesionLipid PeroxidationMediatingModelingMolecularMonitorMultiple SclerosisOncogene ActivationOncogenicOxidation-ReductionOxidative StressPathologicPatientsPhysiologicalPopulationPre-Clinical ModelProcessProteinsReactive Oxygen SpeciesRefluxRegulationResistanceRisk FactorsRoleSignal TransductionStomachTherapeuticTimeTissue SampleTumor Suppressor ProteinsUnited StatesWestern Worldbasebile saltscancer celldruggable targetexperiencefunctional genomicsglutathione peroxidasehigh riskhuman tissueinhibitormembermultiple sclerosis patientneoplasticnoveloverexpressionoxidative DNA damageoxidative damagepreventprognosticresponsesuccesstherapeutic developmenttranscription factortranslational studytumor xenografttumorigenesistumorigenic
项目摘要
ABSTRACT/SUMMARY: The incidence of esophageal adenocarcinoma (EAC) has increased more than six
fold over the past three decades. Chronic gastroesophageal reflux disease (GERD), where acidic bile salts
abnormally refluxate into the esophagus affects almost 20% of adult US population. GERD leads to the
development of a glandular epithelium known as Barrett's esophagus (BE); the main risk factor for the
development of neoplastic lesions; high-grade dysplasia (HGD) and progression to EAC. We and others have
shown that chronic exposure of BE cells to acidic bile salts is associated with a dramatic increase in the burden
of reactive oxygen species (ROS) and oxidative stress. We have found that several members of the
glutathione family members that protect against oxidative stress in BE cells are silenced in neoplastic HGD and
EAC. EAC cells are exposed to high levels of ROS and oxidative stress due to chronic acidic bile reflux and
activation of oncogenes. Failure to control the cumulative levels of ROS and oxidative stress would be lethal to
cancer cells, if they remain uncorrected. We hypothesize that; with the silencing of several antioxidant genes
in progression from BE to HGD/EAC, cancer cells must develop an antioxidant network that prevents
uncontrolled accumulation of ROS. These adaptive mechanisms are crucial in promoting their survival in
response to high levels of ROS due to exposure to acidic bile salts, activation of oncogenes, and treatment
with chemotherapeutics. Our preliminary data demonstrated constitutive high levels of expression of NRF2 in
HGD/EAC, suggesting its role as an intrinsic adaptive molecular mechanism. We show for the first time that
accumulation of NRF2 protein and its activation in EAC is mainly dependent on redox factor 1 (REF1); not on
its physiological inhibitor KEAP1. In this proposal, we will investigate the biological relevance of NRF2
antioxidant functions in regulating ROS, oxidative stress, oxidative DNA damage, gene expression, and cell
survival in response to acidic bile salts and chemotherapeutics. The regulation of NRF2 by REF1 and its
transcription network will be investigated in Aim 1. In Aim 2, we will tackle previously unexplored roles of NRF2
in EAC tumorigenesis and identify the role of NRF2 in EAC cancer cell survival in response to acidic bile salts
and chemotherapeutics. The clinico-pathological significance of NRF2 expression and its significance as a
druggable target will be investigated alone and in combination with existing chemotherapeutics (Aim 3). In
summary, this project addresses gaps in our knowledge and tackles etiology-based biologically relevant
questions to uncover novel information regarding the role of NRF2 in regulating survival and chemotherapeutic
resistance in EAC. The findings are especially important as several NRF2 activators are available over
the counter and are also used to treat some clinical disorders such multiple sclerosis (MS). Treatments
with NRF2 activators may need to be carefully monitored in patients with MS and BE, as they could be at
higher risk for EAC because of NRF2 pro-tumorigenic effects in this setting. Our results could also support
the development of NRF2 inhibitors and provide a novel window of therapeutic opportunity for EAC treatment.
摘要/总结:食管腺癌(EAC)的发病率增加了6
在过去的三十年里,慢性胃食管反流病(GERD),其中酸性胆汁盐
异常反流进入食道影响几乎20%的美国成年人口。GERD导致
腺上皮的发展称为巴雷特食管(BE);
发生肿瘤性病变;高度异型增生(HGD)和进展为EAC。我们和其他人已经
表明BE细胞长期暴露于酸性胆汁盐与负荷的急剧增加有关,
活性氧(ROS)和氧化应激。我们发现,一些成员的
在BE细胞中保护免受氧化应激的谷胱甘肽家族成员在肿瘤性HGD中沉默,
EAC.由于慢性酸性胆汁反流,EAC细胞暴露于高水平的ROS和氧化应激,
致癌基因的激活。如果不能控制ROS和氧化应激的累积水平,
癌细胞,如果他们仍然没有得到纠正。我们假设,随着几个抗氧化基因的沉默,
在从BE到HGD/EAC的发展过程中,癌细胞必须发展一种抗氧化网络,
ROS的不受控制的积累。这些适应机制对于促进它们在环境中的生存至关重要。
由于暴露于酸性胆汁盐、癌基因激活和治疗,对高水平ROS的反应
化疗药物。我们的初步数据表明,NRF2在细胞中的组成性高水平表达。
HGD/EAC,表明其作为一种内在的适应性分子机制的作用。我们第一次发现
EAC中NRF2蛋白的积累及其活化主要依赖于氧化还原因子1(REF 1);而不是
其生理抑制剂KEAP 1。在这个提议中,我们将研究NRF2的生物学相关性,
抗氧化剂在调节ROS、氧化应激、氧化性DNA损伤、基因表达和细胞中的功能,
对酸性胆汁盐和化疗药物的反应。REF 1对NRF 2的调控及其机制
转录网络将在目标1中进行研究。在目标2中,我们将解决NRF2以前未探索的角色
在EAC肿瘤发生中的作用,并确定NRF2在EAC癌细胞存活中对酸性胆汁盐的反应
和化疗药物。NRF2表达的临床病理意义及其作为肿瘤标志物的意义
将单独和与现有的化学治疗剂组合研究可药物化的靶点(目标3)。在
总之,这个项目解决了我们知识的空白,并解决了基于病因的生物学相关问题。
关于NRF2在调节生存和化疗中的作用的新信息的问题
EAC中的电阻。这些发现尤其重要,因为几种NRF2激活剂可在
也用于治疗一些临床疾病,如多发性硬化症(MS)。治疗
在MS和BE患者中,可能需要仔细监测NRF2激活剂,因为它们可能在
EAC的风险更高,因为在这种情况下NRF2的促肿瘤发生作用。我们的研究结果也可以支持
NRF2抑制剂的开发,并为EAC治疗提供了新的治疗机会窗口。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.
- DOI:10.3390/antiox11101859
- 发表时间:2022-09-21
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells.
- DOI:10.1016/j.redox.2021.101970
- 发表时间:2021-07
- 期刊:
- 影响因子:11.4
- 作者:Sriramajayam K;Peng D;Lu H;Zhou S;Bhat N;McDonald OG;Que J;Zaika A;El-Rifai W
- 通讯作者:El-Rifai W
APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
- DOI:10.1186/s13046-022-02472-5
- 发表时间:2022-09-01
- 期刊:
- 影响因子:11.3
- 作者:Ballout, Farah;Lu, Heng;Chen, Lei;Sriramajayam, Kannappan;Que, Jianwen;Meng, Zhipeng;Wang, Timothy C.;Giordano, Silvia;Zaika, Alexander;McDonald, Oliver;Peng, Dunfa;El-Rifai, Wael
- 通讯作者:El-Rifai, Wael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAEL EL-RIFAI其他文献
WAEL EL-RIFAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAEL EL-RIFAI', 18)}}的其他基金
Intercepting novel functions of AURKA in gastric tumorigenesis
拦截 AURKA 在胃肿瘤发生中的新功能
- 批准号:
10663953 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis
食管腺癌肿瘤发生中转录网络的破坏
- 批准号:
10407744 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis
食管腺癌肿瘤发生中转录网络的破坏
- 批准号:
10662298 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma
阐明食管腺癌中新型 APE1 氧化还原依赖性功能
- 批准号:
10662300 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma
阐明食管腺癌中新型 APE1 氧化还原依赖性功能
- 批准号:
10407745 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Intercepting novel functions of AURKA in gastric tumorigenesis
拦截 AURKA 在胃肿瘤发生中的新功能
- 批准号:
10515693 - 财政年份:2022
- 资助金额:
$ 34.41万 - 项目类别:
Molecular Functions of CDK1 in Gastric Tumorigenesis
CDK1在胃肿瘤发生中的分子功能
- 批准号:
10546490 - 财政年份:2021
- 资助金额:
$ 34.41万 - 项目类别:
Molecular Functions of CDK1 in Gastric Tumorigenesis
CDK1在胃肿瘤发生中的分子功能
- 批准号:
10117581 - 财政年份:2021
- 资助金额:
$ 34.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.41万 - 项目类别:
Research Grant